Item no | Recommendation | Reported on page no |
---|---|---|
Reporting of background should include | ||
1 | Problem definition | 3 |
2 | Hypothesis statement | – |
3 | Description of study outcome(s) | 4 |
4 | Type of exposure or intervention used | 4–5 |
5 | Type of study designs used | 4–5 |
6 | Study population | 5 |
Reporting of search strategy should include | ||
7 | Qualifications of searchers (e.g., librarians and investigators) | Title page |
8 | Search strategy, including time period included in the synthesis and key words | 3–4 (Section 2.1) |
9 | Effort to include all available studies, including contact with authors | 3–4 (Section 2.1) |
10 | Databases and registries searched | 3–4 (Section 2.1) |
11 | Search software used, name and version, including special features used (e.g., explosion) | 3–4 (Section 2.1) |
12 | Use of hand searching (e.g., reference lists of obtained articles) | 3–4 (Section 2.1) |
13 | List of citations located and those excluded, including justification | 8, Table 2, Fig. 1 |
14 | Method of addressing articles published in languages other than English | 3–4 (Section 2.1) |
15 | Method of handling abstracts and unpublished studies | 3–4 (Section 2.1) |
16 | Description of any contact with authors | – |
Reporting of methods should include | ||
17 | Description of relevance or appropriateness of studies assembled for assessing the hypothesis to be tested | 3–4 |
18 | Rationale for the selection and coding of data (e.g., sound clinical principles or convenience) | 3–4 |
19 | Documentation of how data were classified and coded (e.g., multiple raters, blinding and interrater reliability) | – |
20 | Assessment of confounding (e.g., comparability of cases and controls in studies where appropriate) | – |
21 | Assessment of study quality, including blinding of quality assessors, stratification or regression on possible predictors of study results | 3–4 Table 2 |
22 | Assessment of heterogeneity | 4 Table 2 |
23 | Description of statistical methods (e.g., complete description of fixed or random-effects models, justification of whether the chosen models account for predictors of study results, dose–response models, or cumulative meta-analysis) in sufficient detail to be replicated | 4 |
24 | Provision of appropriate tables and graphics | Tables 1–2, Figs 1–3 |
Reporting of results should include | ||
25 | Graphic summarizing individual study estimates and overall estimate | Figs 2–3 |
26 | Table giving descriptive information for each study included | Table 1 |
27 | Results of sensitivity testing (e.g., subgroup analysis) | Fig. 3 Table 1 |
28 | Indication of statistical uncertainty of findings | 5 |
Reporting of discussion should include | ||
29 | Quantitative assessment of bias (e.g., publication bias) | 5–6 |
30 | Justification for exclusion (e.g., exclusion of non-English language citations) | 5–6 |
31 | Assessment of quality of included studies | 5–6 (QUADAS assessment) |
Reporting of conclusions should include | ||
32 | Consideration of alternative explanations for observed results | 5–6 |
33 | Generalization of the conclusions (i.e., appropriate for the data presented and within the domain of the literature review) | 5–6 |
34 | Guidelines for future research | 5–6 |
35 | Disclosure of funding source | – |
From: Stroup et al.15 for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA. 2000;283:2008–2012. doi: 10.1001/jama.283.15.2008.